Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized Medicine, Storied Past, Contentious Present, Promising Future.

Journal of personalized medicine·2026
Same author

Recent developments in salivary gland pathology after the WHO 2024 classification: new developments in existing entities and evolving new entities.

Virchows Archiv : an international journal of pathology·2026
Same author

Ultrasound-enhanced fine-needle aspiration biopsy improves yield of solid benign parotid gland tumor tissue: a pilot study.

European radiology experimental·2026
Same author

International Consensus Guidelines for Diagnostic Criteria and Checklist for Future Studies for Minimally Invasive Carcinoma ex Pleomorphic Adenoma: An HN CLEAR Initiative.

Head and neck pathology·2026
Same author

Comprehensive next generation sequencing of middle ear neuroendocrine tumors.

Annals of diagnostic pathology·2026
Same author

Barnaculate Carcinoma in Four Patients: Verrucoid Squamous Cell Carcinoma Subtype with TERT and HRAS Oncogenic Variants.

Head and neck pathology·2026

Related Experiment Video

Updated: Jul 2, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K

Assessing Oral Epithelial Dysplasia Risk for Transformation to Cancer: Comparison Between Histologic Grading Systems

Mark Roger Darling1, Jason T K Hwang2, Benjamin J Dickson3

  • 1Schulich School of Medicine and Dentistry, The University of Western Ontario.

Applied Immunohistochemistry & Molecular Morphology : AIMM
|May 30, 2023
PubMed
Summary

The S100A7 immunohistochemical signature system offers a more accurate and reproducible method for predicting oral cancer transformation compared to traditional 2-tier and 3-tier dysplasia grading systems, which showed poor predictive value.

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

280

Related Experiment Videos

Last Updated: Jul 2, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.6K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

280

Area of Science:

  • Oral pathology
  • Biomarker research
  • Cancer risk assessment

Background:

  • Traditional 3-tier oral epithelial dysplasia grading is suboptimal for predicting cancer transformation.
  • A 2-tier system has been proposed but lacks validation.
  • Objective risk assessment tools are needed for oral dysplasia.

Purpose of the Study:

  • Compare the predictive accuracy of 3-tier and 2-tier dysplasia grading systems with an S100A7 immunohistochemical signature.
  • Evaluate inter-observer variability and prediction of oral cancer transformation for each system.

Main Methods:

  • Retrospective analysis of 48 patient biopsy specimens with known outcomes.
  • Grading using hematoxylin and eosin stains (2- and 3-tier) and S100A7 immunohistochemistry.
  • Inter-observer variability assessed with Cohen's kappa; survival analysis using Cox regression.

Main Results:

  • Both 2- and 3-tier systems showed slight to substantial inter-observer agreement (Kw 0.093-0.624) and poor cancer transformation prediction (P > 0.05).
  • The S100A7 signature system demonstrated almost perfect inter-observer agreement (Kw = 0.892) and was a significant predictor of transformation (P = 0.047, 0.030).

Conclusions:

  • Traditional oral dysplasia grading systems have significant limitations in predicting oral cancer risk.
  • The S100A7 immunohistochemical signature system provides a more objective, quantitative, and reproducible tool for risk assessment.
  • This novel biomarker signature system shows promise for improving patient management and outcomes in oral potentially malignant disorders.